{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:35:13Z","timestamp":1782995713016,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lana.2024.100943","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T22:40:56Z","timestamp":1731451256000},"page":"100943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Excess burden of antibiotic-resistant bloodstream infections: evidence from a multicentre retrospective cohort study in Chile, 2018\u20132022"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2144-7181","authenticated-orcid":false,"given":"Kasim","family":"Allel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Haghparast-Bidgoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Spencer-Sandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Conejeros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen B.","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8639-4511","authenticated-orcid":false,"given":"Laith","family":"Yakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Munita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-1253","authenticated-orcid":false,"given":"Eduardo A.","family":"Undurraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10325","key":"10.1016\/j.lana.2024.100943_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.lana.2024.100943_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(18)30471-7","article-title":"Antimicrobial resistance: a threat to global health","volume":"18","author":"Jee","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6435","key":"10.1016\/j.lana.2024.100943_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau4679","article-title":"The challenge of antimicrobial resistance: what economics can contribute","volume":"364","author":"Roope","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.lana.2024.100943_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-018-0336-y","article-title":"Estimating the burden of antimicrobial resistance: a systematic literature review","volume":"7","author":"Naylor","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"10","key":"10.1016\/j.lana.2024.100943_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/1469-0691.12798","article-title":"Economic burden of antibiotic resistance: how much do we really know?","volume":"20","author":"Gandra","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"10459","key":"10.1016\/j.lana.2024.100943_bib6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.lana.2024.100943_bib7","first-page":"100561","article-title":"The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis","volume":"25","author":"Aguilar","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.lana.2024.100943_bib8","series-title":"Stemming the superbug tide: just a few dollars more","year":"2019"},{"issue":"6","key":"10.1016\/j.lana.2024.100943_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004199","article-title":"The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low-and middle-income countries: a systematic review and meta-analysis","volume":"20","author":"Allel","year":"2023","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.lana.2024.100943_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jhin.2017.11.011","article-title":"Intensive care unit (ICU)-acquired bacteraemia and ICU mortality and discharge: addressing time-varying confounding using appropriate methodology","volume":"99","author":"Pouwels","year":"2018","journal-title":"J\u00a0Hosp Infect"},{"issue":"9","key":"10.1016\/j.lana.2024.100943_bib11","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1093\/cid\/ciaa136","article-title":"Estimating the effect of healthcare-associated infections on excess length of hospital stay using inverse probability\u2013weighted survival curves","volume":"71","author":"Pouwels","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lana.2024.100943_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jgar.2020.12.005","article-title":"Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: a 10-year study in a tertiary-care centre in Mexico City","volume":"24","author":"L\u00f3pez-Luis","year":"2021","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.lana.2024.100943_bib13","series-title":"CLSI Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement M100-S24 January","year":"2014"},{"issue":"3","key":"10.1016\/j.lana.2024.100943_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lana.2024.100943_bib15","doi-asserted-by":"crossref","first-page":"101781","DOI":"10.1016\/j.eclinm.2022.101781","article-title":"Antimicrobial resistance and mortality following E. coli bacteremia","volume":"56","author":"Daneman","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"9","key":"10.1016\/j.lana.2024.100943_bib16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1469-0691.2010.03089.x","article-title":"Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals","volume":"16","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.lana.2024.100943_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.lana.2024.100943_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.lana.2024.100943_bib19","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2147\/IDR.S177247","article-title":"Health care-associated infections\u2013an overview","volume":"11","author":"Haque","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.lana.2024.100943_bib20","series-title":"ATC\/DDD index 2023","year":"2023"},{"key":"10.1016\/j.lana.2024.100943_bib21","series-title":"Aranceles mai","year":"2023"},{"key":"10.1016\/j.lana.2024.100943_bib23","series-title":"GLASS method for estimating attributable mortality of antimicrobial resistant bloodstream infections","author":"Organization WH","year":"2020"},{"issue":"2","key":"10.1016\/j.lana.2024.100943_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jac\/dkq412","article-title":"Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins","volume":"66","author":"De Kraker","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"446","key":"10.1016\/j.lana.2024.100943_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"4","key":"10.1016\/j.lana.2024.100943_bib26","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1128\/AAC.01157-10","article-title":"Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"55","author":"de Kraker","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.lana.2024.100943_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.lana.2024.100943_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lana.2024.100943_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jac\/dkx350","article-title":"Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study","volume":"73","author":"Seas","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.lana.2024.100943_bib30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/ice.2017.197","article-title":"Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis","volume":"38","author":"Kohler","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.lana.2024.100943_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"10.1016\/j.lana.2024.100943_bib32","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/JCM.41.8.3655-3660.2003","article-title":"Epidemiology and outcome of nosocomial and community-onset bloodstream infection","volume":"41","author":"Diekema","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.lana.2024.100943_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2011.03478.x","article-title":"Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections","volume":"18","author":"Ben-David","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.lana.2024.100943_bib34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/cid\/cix411","article-title":"Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms","volume":"65","author":"Barrasa-Villar","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.lana.2024.100943_bib35","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/CCM.0000000000001164","article-title":"Community-, healthcare-and hospital-acquired severe sepsis hospitalizations in the University HealthSystem consortium","volume":"43","author":"Page","year":"2015","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.lana.2024.100943_bib36","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.lana.2024.100943_bib37","first-page":"345","article-title":"Economic burden of methicillin-resistant Staphylococcus aureus bacteremia in critical care patients in hospitals in Bogot\u00e1","volume":"34","author":"Barrero","year":"2014","journal-title":"Biomedica"},{"issue":"suppl_2","key":"10.1016\/j.lana.2024.100943_bib38","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/cid\/ciy642","article-title":"In-hospital medical costs of infections caused by carbapenem-resistant Klebsiella pneumoniae","volume":"67","author":"Huang","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lana.2024.100943_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2015.06.014","article-title":"Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant Acinetobacter baumannii","volume":"38","author":"Gulen","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.lana.2024.100943_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285170","article-title":"The economic burden of antibiotic resistance: a systematic review and meta-analysis","volume":"18","author":"Poudel","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lana.2024.100943_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12962-021-00260-0","article-title":"Cost per DALY averted in low, middle-and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds","volume":"19","author":"Daroudi","year":"2021","journal-title":"Cost Eff Resour Alloc"},{"issue":"10258","key":"10.1016\/j.lana.2024.100943_bib42","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.lana.2024.100943_bib43","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciac364","article-title":"Persistent methicillin-resistant Staphylococcus aureus bacteremia: resetting the clock for optimal management","volume":"75","author":"Holland","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.lana.2024.100943_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals","volume":"21","author":"Kadri","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.lana.2024.100943_bib45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/172.4.993","article-title":"Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections","volume":"172","author":"Shay","year":"1995","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.lana.2024.100943_bib46","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/502271","article-title":"Outcomes associated with vancomycin-resistant enterococci: a meta-analysis","volume":"24","author":"Salgado","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"19","key":"10.1016\/j.lana.2024.100943_bib47","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/archinte.162.19.2223","article-title":"Health and economic outcomes of vancomycin-resistant enterococci","volume":"162","author":"Carmeli","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lana.2024.100943_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-018-0419-9","article-title":"The importance of adjusting for enterococcus species when assessing the burden of\u00a0vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections","volume":"7","author":"Kramer","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"10.1016\/j.lana.2024.100943_bib49","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/cid\/ciz1200","article-title":"Are vancomycin-resistant enterococcal bloodstream infections associated with decreased survival?","volume":"71","author":"Piezzi","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.lana.2024.100943_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02463-22","article-title":"Genomic analysis of carbapenem-resistant Acinetobacter baumannii strains recovered from Chilean hospitals reveals lineages specific to South America and multiple routes for acquisition of antibiotic resistance genes","volume":"10","author":"Brito","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.lana.2024.100943_bib51","first-page":"100484","article-title":"Trends and socioeconomic, demographic, and environmental factors associated with antimicrobial resistance: a longitudinal analysis in 39 hospitals in Chile 2008\u20132017","volume":"21","author":"Allel","year":"2023","journal-title":"Lancet Reg Health Am"},{"issue":"10","key":"10.1016\/j.lana.2024.100943_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00816-17","article-title":"A\u00a0prospective cohort multicenter study of molecular epidemiology and phylogenomics of Staphylococcus aureus bacteremia in nine Latin American countries","volume":"61","author":"Arias","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.lana.2024.100943_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2811.220415","article-title":"Increased detection of carbapenemase-producing enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic","volume":"28","author":"Thomas","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"Supplement_1","key":"10.1016\/j.lana.2024.100943_bib54","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/ciad151","article-title":"Antibiotic consumption during the coronavirus disease 2019 pandemic and emergence of carbapenemase-producing Klebsiella pneumoniae lineages among inpatients in a Chilean hospital: a time-series study and phylogenomic analysis","volume":"77","author":"Allel","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.lana.2024.100943_bib55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmi.2022.12.006","article-title":"Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis","volume":"29","author":"Langford","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lana.2024.100943_bib56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s100960050483","article-title":"Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia","volume":"19","author":"Hekker","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.lana.2024.100943_bib57","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3201\/eid1307.070187","article-title":"Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections","volume":"13","author":"Victor","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.lana.2024.100943_bib58","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.lana.2024.100943_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhin.2004.12.025","article-title":"Estimating the proportion of community-associated methicillin-resistant Staphylococcus aureus: two definitions used in the USA yield dramatically different estimates","volume":"60","author":"Folden","year":"2005","journal-title":"J\u00a0Hosp Infect"},{"issue":"10","key":"10.1016\/j.lana.2024.100943_bib60","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archinte.158.10.1127","article-title":"The role of colonization pressure in the spread of vancomycin-resistant enterococci: an important infection control variable","volume":"158","author":"Bonten","year":"1998","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.lana.2024.100943_bib61","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1086\/514196","article-title":"Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients","volume":"177","author":"Bonten","year":"1998","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.lana.2024.100943_bib62","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1073\/pnas.0400456101","article-title":"Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem","volume":"101","author":"Smith","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.lana.2024.100943_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.lana.2024.100943_bib64","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/S1473-3099(22)00877-5","article-title":"Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review","volume":"23","author":"Rice","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lana.2024.100943_bib65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.vhri.2021.07.009","article-title":"Cost-effectiveness of molecular method diagnostic for rapid detection of antibiotic-resistant bacteria","volume":"27","author":"Salvador","year":"2022","journal-title":"Value Health Reg Issues"},{"issue":"2","key":"10.1016\/j.lana.2024.100943_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-013205","article-title":"Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review","volume":"9","author":"Allel","year":"2024","journal-title":"BMJ Glob Health"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X24002709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X24002709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T16:02:04Z","timestamp":1736524924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X24002709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S2667193X24002709"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2024.100943","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excess burden of antibiotic-resistant bloodstream infections: evidence from a multicentre retrospective cohort study in Chile, 2018\u20132022","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2024.100943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100943"}}